Huntington National Bank boosted its stake in shares of Danaher Co. (NYSE:DHR) by 5.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 76,355 shares of the conglomerate’s stock after buying an additional 3,777 shares during the period. Huntington National Bank’s holdings in Danaher were worth $10,080,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc grew its position in Danaher by 1.4% during the third quarter. Vanguard Group Inc now owns 44,738,984 shares of the conglomerate’s stock worth $4,861,338,000 after buying an additional 605,018 shares during the period. BlackRock Inc. grew its holdings in shares of Danaher by 0.5% during the fourth quarter. BlackRock Inc. now owns 43,634,997 shares of the conglomerate’s stock worth $4,499,639,000 after purchasing an additional 207,468 shares during the last quarter. FMR LLC grew its holdings in shares of Danaher by 1.4% during the fourth quarter. FMR LLC now owns 22,035,846 shares of the conglomerate’s stock worth $2,272,336,000 after purchasing an additional 296,095 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Danaher by 8.4% during the fourth quarter. Geode Capital Management LLC now owns 7,527,142 shares of the conglomerate’s stock worth $774,743,000 after purchasing an additional 583,194 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Danaher during the fourth quarter worth about $747,082,000. Institutional investors own 77.59% of the company’s stock.
Several analysts have recently weighed in on the company. Needham & Company LLC boosted their price target on Danaher from $138.00 to $141.00 and gave the stock a “buy” rating in a report on Wednesday. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $147.00 price target on the stock in a research note on Tuesday, April 9th. JPMorgan Chase & Co. restated an “overweight” rating and set a $140.00 target price on shares of Danaher in a research report on Monday, March 4th. Jefferies Financial Group upped their price objective on shares of Danaher to $140.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Finally, Deutsche Bank raised their target price on shares of Danaher to $130.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. Danaher currently has a consensus rating of “Buy” and an average price target of $125.69.
Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.01. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The business had revenue of $5.40 billion for the quarter, compared to the consensus estimate of $5.33 billion. During the same period last year, the firm posted $1.19 earnings per share. The firm’s quarterly revenue was up 6.2% compared to the same quarter last year. As a group, equities research analysts forecast that Danaher Co. will post 4.79 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be issued a $0.17 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.16. The ex-dividend date is Thursday, March 28th. This represents a $0.68 annualized dividend and a dividend yield of 0.54%. Danaher’s dividend payout ratio is presently 15.04%.
In other news, CAO Robert S. Lutz sold 15,000 shares of the company’s stock in a transaction dated Sunday, February 24th. The shares were sold at an average price of $127.00, for a total value of $1,905,000.00. Following the sale, the chief accounting officer now owns 22,251 shares of the company’s stock, valued at approximately $2,825,877. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Angela S. Lalor sold 4,534 shares of the company’s stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $127.25, for a total transaction of $576,951.50. Following the completion of the sale, the senior vice president now directly owns 21,209 shares in the company, valued at approximately $2,698,845.25. The disclosure for this sale can be found here. In the last ninety days, insiders sold 183,150 shares of company stock worth $23,279,637. 11.40% of the stock is owned by insiders.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: SEC Filing
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.